Teleflex (TFX) — insider trading
Health Care · NYSE
Teleflex (TFX) has 21 reported SEC Form 4 insider transactions in our data (latest 2026-09-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Salmon Sean | Director | Grant / award / vesting (derivative) | 4,444 | — | $0 | Form 4 |
| 2026-09-08 | Salmon Sean | Director | Grant / award / vesting | 674 | — | $0 | Form 4 |
| 2026-06-08 | Weidman Jason R. | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 26,071 | — | $0 | Form 4 |
| 2026-06-08 | Weidman Jason R. | Director, Officer (President and CEO) | Grant / award / vesting | 53,983 | — | $0 | Form 4 |
| 2026-06-08 | RANDLE STUART A | Director | Grant / award / vesting (derivative) | 2,192 | — | $0 | Form 4 |
| 2026-06-08 | RANDLE STUART A | Director | Grant / award / vesting | 4,663 | — | $0 | Form 4 |
| 2026-06-08 | RANDLE STUART A | Director | Grant / award / vesting | 995 | — | $0 | Form 4 |
| 2026-06-07 | RANDLE STUART A | Director | Shares withheld for taxes / exercise cost | 4,054 | $129.84 | $526.4K | Form 4 |
| 2026-05-15 | Patil Neena M | Director | Grant / award / vesting (derivative) | 2,397 | — | $0 | Form 4 |
| 2026-05-15 | Patil Neena M | Director | Grant / award / vesting | 1,090 | — | $0 | Form 4 |
| 2026-05-15 | TOKICH MICHAEL J | Director | Grant / award / vesting (derivative) | 4,793 | — | $0 | Form 4 |
| 2026-05-15 | TOKICH MICHAEL J | Director | Grant / award / vesting | 1,090 | — | $0 | Form 4 |
| 2026-05-15 | Duncan Candace H | Director | Grant / award / vesting (derivative) | 2,397 | — | $0 | Form 4 |
| 2026-05-15 | Duncan Candace H | Director | Grant / award / vesting | 1,090 | — | $0 | Form 4 |
| 2026-05-15 | HAGGERTY GRETCHEN R | Director | Grant / award / vesting (derivative) | 2,397 | — | $0 | Form 4 |
| 2026-05-15 | HAGGERTY GRETCHEN R | Director | Grant / award / vesting | 1,090 | — | $0 | Form 4 |
| 2026-05-15 | Krakauer Andrew A | Director | Grant / award / vesting (derivative) | 2,397 | — | $0 | Form 4 |
| 2026-05-15 | Krakauer Andrew A | Director | Grant / award / vesting | 1,090 | — | $0 | Form 4 |
| 2026-05-15 | Ryu Jaewon | Director | Grant / award / vesting (derivative) | 2,397 | — | $0 | Form 4 |
| 2026-05-15 | Ryu Jaewon | Director | Grant / award / vesting | 1,090 | — | $0 | Form 4 |
| 2026-05-09 | RANDLE STUART A | Director, Officer (Interim President and CEO) | Shares withheld for taxes / exercise cost | 289 | $133.06 | $38.5K | Form 4 |
Ask the chat about TFX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Teleflex (TFX).
Last updated 2026-09-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.